Radiation Therapy in Treating Patients With Metastatic Spinal Cord Compression
SCORAD: A Randomised Feasibility Study of Single Fraction Radiotherapy Compared to Multi-fraction Radiotherapy in Patients With Metastatic Spinal Cord Compression
5 other identifiers
interventional
100
1 country
4
Brief Summary
RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. It is not yet known which radiation therapy regimen is more effective in treating metastatic spinal cord compression. PURPOSE: This randomized clinical trial is comparing two radiation therapy regimens to see how well they work in treating patients with metastatic spinal cord compression.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2007
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2007
CompletedFirst Submitted
Initial submission to the registry
August 1, 2008
CompletedFirst Posted
Study publicly available on registry
August 4, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2009
CompletedAugust 26, 2013
June 1, 2009
1.3 years
August 1, 2008
August 23, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient accrual per center over a 12-month period
Secondary Outcomes (9)
Ambulatory status at 1, 4, 8, and 12 weeks from day 1 of treatment compared to baseline
Bladder and bowel function at 1, 4, 8, and 12 weeks from day 1 of treatment compared to baseline
Acute side effects using RTOG scales at 1, 4, 8, and 12 weeks from day 1 of treatment
Quality of life as measured by the EORTC QLQ-C30 questionnaire at 1, 4, 8, and 12 weeks from day 1 of treatment compared to baseline
Further treatment
- +4 more secondary outcomes
Study Arms (2)
Arm I (multi-fraction radiotherapy)
ACTIVE COMPARATORPatients undergo 5 fractions of 20 Gy external-beam radiotherapy.
Arm II (single-fraction radiotherapy)
EXPERIMENTALPatients undergo 1 fraction of 8 Gy external beam radiotherapy.
Interventions
Patients undergo external beam radiotherapy
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Study Sites (4)
Bristol Haematology and Oncology Centre
Bristol, England, BS2 8ED, United Kingdom
Cancer Research UK and University College London Cancer Trials Centre
Northwood, England, HA6 2RN, United Kingdom
Glan Clwyd Hospital
Rhyl, Denbighshire, Wales, LL 18 5UJ, United Kingdom
Christie Hospital
Manchester, M20 6UX, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Peter J. Hoskin, MD
Mount Vernon Cancer Centre at Mount Vernon Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
August 1, 2008
First Posted
August 4, 2008
Study Start
November 1, 2007
Primary Completion
February 1, 2009
Study Completion
August 1, 2009
Last Updated
August 26, 2013
Record last verified: 2009-06